The Race for a Covid Vaccine Was More About Luck Than Tech
Pfizer-BioNTech and Moderna’s mRNA platforms are amazing—but they could easily have been overtaken by more conventional rivals.
Covid-19 Vaccines With ‘Minor Side Effects’ Could Still Be Pretty Bad
The risk of nasty side effects in the Moderna and Oxford trials should be made clear now, before it ends up as fodder for the skeptics.
What the Data Really Says About Women Leaders and the Pandemic
Two new research papers try to shed some light on a popular theory, but the evidence is still very weak—and could point to confirmation bias.
Social Distancing Has Become the Norm. What Have We Learned?
It’s a good time to sort through what’s known, unknown, and only just beginning to be understood about this months-long intervention.